Heart Surgery News and Research

RSS

Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.

The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor.

30 Nov 2011

Heart operation at the age of 22 hours: Toby’s story

A 22 hours age, baby Toby Dring became Britain’s youngest open heart surgery patient. He had Hypoplastic Left Heart Syndrome and had to be given the life-saving operation when his health deteriorated dramatically at birth. Toby’s condition affects one in 5,000 babies and occurs when the left side of the heart fails to form properly.

28 Nov 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Drilling through concrete to create an opening may sound more like construction than medicine, but the approach is similar to what researchers at Orlando Regional Medical Center (ORMC) are doing in a clinical trial to evaluate a device that breaks through hardened coronary arteries, in an effort to prevent heart attacks and relieve chest pain.

23 Nov 2011

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston and Memorial Hermann Heart & Vascular Institute are the first in Houston to implant the artificial heart valve recently approved by the Food and Drug Administration, as well as a newer, smaller version that is part of a clinical trial.

21 Nov 2011

Study: Pneumonia the most common serious infection post-heart surgery

Pneumonia - not a deep incision surgical site infection - is the most common serious infection after heart surgery, according to new research presented at the American Heart Association's Scientific Sessions 2011.

16 Nov 2011

Study compares safety of procedures at hospitals with and without cardiac surgery backup

Hospitals that do not have cardiac surgery capability can perform nonemergency angioplasty and stent implantation as safely as hospitals that do offer cardiac surgery. That is the finding of the nation's first large, randomized study to assess whether patients do just as well having nonemergency angioplasty performed at smaller, community hospitals that do not offer cardiac surgery.

15 Nov 2011

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the search for an improved method of treating atrial fibrillation (AF) will be unaffected by the recent mixed decision by the Food and Drug Administration (FDA) panel on Medtronic's phased radiofrequency (RF) pulmonary vein ablation catheter (PVAC).

From Medtronic 14 Nov 2011

Second molecular conductor discovered in some children with biliary atresia

Unexpected discovery of a new molecular signature for a destructive and often lethal pediatric liver disease may lead to a new therapeutic target for the hard-to-treat condition.

9 Nov 2011

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.

From Medtronic 7 Nov 2011

First U.S. transcatheter aortic heart valve implant performed at NewYork-Presbyterian/Columbia

NewYork-Presbyterian Hospital/Columbia University Medical Center today became the first in the United States to implant the SAPIEN transcatheter aortic heart valve as an FDA-approved standard of care.

5 Nov 2011

UCSD experts use hybrid OR to perform first-ever coronary revascularization procedure

UC San Diego Sulpizio Cardiovascular Center experts have performed San Diego's first-ever coronary revascularization procedure using a hybrid operating room, the only facility of its kind in the region. The state-of-the-art operating room allows patients to be treated in one place at one time without having to schedule multiple procedures.

4 Nov 2011

Edwards Life Sciences heart valve approved in the US

The U.S. Food and Drug Administration (FDA) this Wednesday approved the sale of Edwards Life Sciences Corp's Sapien heart valve for patients deemed too sick to have open-heart surgery.

3 Nov 2011

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.

3 Nov 2011

Medtronic initiates CoreValve System trial to treat severe aortic stenosis in Japan

Medtronic, Inc. today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve System.

From Medtronic 3 Nov 2011

Edwards Lifescience receives FDA approval for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery.

3 Nov 2011

Johns Hopkins breast cancer researcher wins BioMaryland LIFE Prize

A Johns Hopkins breast cancer researcher is the recipient of a $50,000 award designed to encourage rapid translation of her basic research on biomarkers into a commercially available test that could predict the best treatment options for some women with breast cancer.

2 Nov 2011

Cardiac rehab boosts longevity, especially in patients with lowest fitness levels

Cardiac rehabilitation boosts longevity, especially in patients with the lowest fitness levels, Dr. Billie-Jean Martin today told the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

24 Oct 2011

Specific dopamine system gene variants linked to ADHD medication response in children

Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate the guesswork from prescribing effective medications for children with ADHD.

22 Oct 2011

Tips for parents, drivers to keep kids safe during Halloween

On average, twice as many kids are killed in pedestrian accidents on Halloween compared to other days of the year. In an effort to keep kids safe this season, injury prevention experts from the University of Michigan's C.S. Mott Children's Hospital urge parents to prepare children to act safely and drivers to take extra precautions.

21 Oct 2011

U.S. News ranks Meridian Health among 2011-2012 Best Hospitals

Jersey Shore University Medical Center, Ocean Medical Center and Riverview Medical Center, all members of Meridian Health, are included in the 2011-2012 Best Hospitals metro area rankings released by U.S. News & World Report.

19 Oct 2011

Heart Surgery News and Research

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

Heart operation at the age of 22 hours: Toby’s story

Study evaluates safety and effectiveness of Diamondback device for heart attacks

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Study: Pneumonia the most common serious infection post-heart surgery

Study compares safety of procedures at hospitals with and without cardiac surgery backup

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

Second molecular conductor discovered in some children with biliary atresia

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

First U.S. transcatheter aortic heart valve implant performed at NewYork-Presbyterian/Columbia

UCSD experts use hybrid OR to perform first-ever coronary revascularization procedure

Edwards Life Sciences heart valve approved in the US

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

Medtronic initiates CoreValve System trial to treat severe aortic stenosis in Japan

Edwards Lifescience receives FDA approval for Sapien Transcatheter Heart Valve

Johns Hopkins breast cancer researcher wins BioMaryland LIFE Prize

Cardiac rehab boosts longevity, especially in patients with lowest fitness levels

Specific dopamine system gene variants linked to ADHD medication response in children

Tips for parents, drivers to keep kids safe during Halloween

U.S. News ranks Meridian Health among 2011-2012 Best Hospitals

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News